Oral lichenoid eruption associated with imatinib treatment

Auteur(s) : Cristina Gomez Fernandez1, Elena Sendagorta Cudos1, Beatriz Casado Verrier1, Marta Feito Rodriguez1, Judith Suarez Aguado2, Carmen Vidaurrazaga Diaz de Arcaya1 1Universitary Hospital La Paz. Department of Dermatology, Paseo de la Castellana, 261, 28046 Madrid, Spain 2Universitary Hospital La Paz. Department of Pathology, Paseo de la Castellana, 261, 28046 Madrid, Spain Imatinib mesylate (Glivec®, formally known as STI571), which was approved in 2001, is a [...]